Interact to see
Advertisement
Advertisement
NUV vs OVM
NUV vs OVM Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
NUV vs. OVM commentary
Jul 27, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUV is a Hold and OVM is a Buy.
SUMMARIES
FUNDAMENTALS
Fundamentals
NUV has more net assets: 1.83B vs. OVM (26.6M). NUV has a higher annual dividend yield than OVM: NUV (2.068) vs OVM (-1.357). NUV was incepted earlier than OVM: NUV (38 years) vs OVM (6 years). NUV (0.47) has a lower expense ratio than OVM (0.83). NUV has a higher turnover OVM (12.00) vs OVM (12.00).
| NUV | OVM | NUV / OVM | |
| Gain YTD | 2.068 | -1.357 | -152% |
| Net Assets | 1.83B | 26.6M | 6,883% |
| Total Expense Ratio | 0.47 | 0.83 | 57% |
| Turnover | 21.00 | 12.00 | 175% |
| Yield | 4.22 | 5.29 | 80% |
| Fund Existence | 38 years | 6 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| NUV | OVM | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 70% | 2 days ago 56% |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 68% |
| Momentum ODDS (%) | 2 days ago 69% | 2 days ago 46% |
| MACD ODDS (%) | 2 days ago 76% | 2 days ago 53% |
| TrendWeek ODDS (%) | 2 days ago 70% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 74% | 2 days ago 66% |
| Advances ODDS (%) | 2 days ago 76% | 2 days ago 67% |
| Declines ODDS (%) | 4 days ago 76% | 11 days ago 65% |
| BollingerBands ODDS (%) | 2 days ago 83% | 2 days ago 44% |
| Aroon ODDS (%) | 2 days ago 70% | 2 days ago 54% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ASVYX | 10.27 | 0.07 | +0.69% |
| American Century Small Cap Value Y | |||
| VITSX | 152.68 | 0.67 | +0.44% |
| Vanguard Total Stock Market Idx I | |||
| GRLLX | 20.15 | 0.08 | +0.40% |
| Goldman Sachs Enhanced U.S. Equity R | |||
| PDIAX | 22.54 | 0.07 | +0.31% |
| Virtus KAR Equity Income A | |||
| FBTCX | 21.71 | N/A | N/A |
| Fidelity Advisor Biotechnology C | |||